(0.15%) 5 214.25 points
(0.16%) 39 059 points
(-0.01%) 18 193 points
(-0.32%) $78.23
(-0.14%) $2.19
(0.04%) $2 332.10
(0.20%) $27.67
(1.93%) $983.50
(-0.04%) $0.928
(0.32%) $10.86
(0.06%) $0.796
(-0.82%) $90.60
Live Chart Being Loaded With Signals
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products...
Stats | |
---|---|
आज की मात्रा | 1.68M |
औसत मात्रा | 1.01M |
बाजार मूल्य | 178.36M |
EPS | £0 ( 2024-04-09 ) |
Last Dividend | £1.184 ( 2023-06-22 ) |
Next Dividend | £0 ( N/A ) |
P/E | -33.01 |
ATR14 | £0.122 (0.37%) |
मात्रा सहसंबंध
Alliance Pharma PLC सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
RCN.L | 0.919 |
XUEB.L | 0.905 |
BIRG.L | 0.905 |
AIBG.L | 0.902 |
FOG.L | 0.896 |
EBQ.L | 0.885 |
NUM.L | 0.883 |
DTY.L | 0.881 |
EMAU.L | 0.871 |
CLIN.L | 0.867 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
TEP.L | -0.906 |
3NIS.L | -0.896 |
LNGA.L | -0.885 |
GFIN.L | -0.884 |
INHC.L | -0.882 |
PTRO.L | -0.882 |
GIF.L | -0.882 |
BIDS.L | -0.878 |
ECHO.L | -0.872 |
PUR.L | -0.871 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Alliance Pharma PLC सहसंबंध - मुद्रा/वस्त्र
Alliance Pharma PLC वित्तीय
Annual | 2022 |
राजस्व: | £167.42M |
सकल लाभ: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2022 |
राजस्व: | £167.42M |
सकल लाभ: | £101.68M (60.74 %) |
EPS: | £0.00170 |
FY | 2021 |
राजस्व: | £163.21M |
सकल लाभ: | £109.45M (67.06 %) |
EPS: | £0.0137 |
FY | 2020 |
राजस्व: | £129.80M |
सकल लाभ: | £82.82M (63.80 %) |
EPS: | £0.0154 |
Financial Reports:
No articles found.
Alliance Pharma PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0.592 (N/A) |
£0 (N/A) |
£1.184 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | £0.0700 | 2009-12-02 |
Last Dividend | £1.184 | 2023-06-22 |
Next Dividend | £0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 28 | -- |
Total Paid Out | £15.63 | -- |
Avg. Dividend % Per Year | 1.27% | -- |
Score | 3.3 | -- |
Div. Sustainability Score | 6.61 | |
Div.Growth Potential Score | 3.44 | |
Div. Directional Score | 5.03 | -- |
Year | Amount | Yield |
---|---|---|
2009 | £0.0700 | 2.33% |
2010 | £0.400 | 1.48% |
2011 | £0.650 | 2.11% |
2012 | £0.775 | 2.51% |
2013 | £0.853 | 2.67% |
2014 | £0.938 | 2.32% |
2015 | £1.033 | 2.79% |
2016 | £1.137 | 2.65% |
2017 | £1.250 | 2.75% |
2018 | £1.375 | 2.04% |
2019 | £1.513 | 2.30% |
2020 | £0.536 | 0.63% |
2021 | £2.20 | 2.50% |
2022 | £1.720 | 1.57% |
2023 | £1.184 | 2.17% |
2024 | £0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
UKW.L | Dividend King | 2023-08-10 | Quarterly | 12 | 3.18% | |
MIDW.L | Dividend Knight | 2023-09-21 | Annually | 9 | 1.73% | |
CVSG.L | Ex Dividend Knight | 2023-11-02 | Annually | 14 | 0.12% | |
SDY.L | Dividend Knight | 2023-08-10 | Annually | 33 | 2.31% | |
HWG.L | Dividend Knight | 2023-09-21 | Semi-Annually | 32 | 0.78% | |
BGEO.L | Dividend Knight | 2023-10-05 | Annually | 14 | 3.65% | |
WTAN.L | Dividend King | 2023-08-24 | Quarterly | 53 | 1.48% | |
NEXS.L | Dividend Junior | 2023-06-01 | Annually | 8 | 0.56% | |
EGY.L | Dividend King | 2023-08-24 | Quarterly | 3 | 2.58% | |
SPO.L | Dividend Knight | 2023-07-27 | Sporadic | 3 | 61.25% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0415 | 1.500 | -0.830 | -1.245 | [0 - 0.5] |
returnOnAssetsTTM | -0.0137 | 1.200 | -0.458 | -0.550 | [0 - 0.3] |
returnOnEquityTTM | -0.0250 | 1.500 | -1.389 | -2.08 | [0.1 - 1] |
payoutRatioTTM | -1.315 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.931 | 0.800 | 5.35 | 4.28 | [1 - 3] |
quickRatioTTM | 1.333 | 0.800 | 6.86 | 5.49 | [0.8 - 2.5] |
cashRatioTTM | 0.533 | 1.500 | 8.15 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.242 | -1.500 | 5.96 | -8.94 | [0 - 0.6] |
interestCoverageTTM | 3.05 | 1.000 | 9.98 | 9.98 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.449 | -1.500 | 8.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.516 | 1.000 | 4.74 | 4.74 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.144 | 1.000 | 9.13 | 9.13 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.174 | 1.000 | -0.143 | -0.143 | [0.2 - 2] |
assetTurnoverTTM | 0.331 | 0.800 | -1.127 | -0.901 | [0.5 - 2] |
Total Score | 6.61 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.32 | 1.000 | -2.66 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0250 | 2.50 | -0.893 | -2.08 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0397 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.58 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0402 | 2.00 | 9.99 | 10.00 | [0 - 30] |
payoutRatioTTM | -1.315 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | 87.66 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.128 | 1.000 | 9.31 | 0 | [0.1 - 0.5] |
Total Score | 3.44 |
Alliance Pharma PLC
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं